$437 Million is the total value of Capital Advantage, Inc.'s 41 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 18.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FLOT | Sell | iShares Floating Rate ETFetf | $35,790,000 | -0.4% | 711,955 | -1.1% | 8.19% | +3.4% |
| FLTR | Sell | VanEck IG Floating Rate ETFetf | $26,459,000 | -0.1% | 1,065,157 | -0.7% | 6.06% | +3.8% |
| VHT | Sell | Vanguard Health Care ETFetf | $23,748,000 | -6.6% | 106,162 | -1.7% | 5.44% | -3.0% |
| LQDH | Sell | iShares Interest Rate Hedged Corp Bd ETFetf | $22,403,000 | -5.9% | 252,454 | -4.3% | 5.13% | -2.3% |
| VIG | Sell | Vanguard Dividend Appreciation ETFetf | $17,350,000 | -6.1% | 128,366 | -0.3% | 3.97% | -2.5% |
| XLF | Sell | Financial Select Sector SPDRetf | $16,730,000 | -8.4% | 551,044 | -5.2% | 3.83% | -4.9% |
| AAPL | Sell | Apple Incequities | $8,349,000 | +0.6% | 60,414 | -0.5% | 1.91% | +4.4% |
| VBR | Sell | Vanguard Small Cap Value Index ETFetf | $7,714,000 | -8.0% | 53,796 | -3.9% | 1.76% | -4.5% |
| SCHM | Sell | Schwab US Mid Cap ETFetf | $6,221,000 | -7.9% | 102,774 | -4.6% | 1.42% | -4.4% |
| IPAC | Sell | iShares Core MSCI Pacific ETFetf | $1,756,000 | -25.6% | 36,625 | -19.4% | 0.40% | -22.7% |
| INTC | Sell | Intel Corpequities | $508,000 | -34.9% | 19,726 | -5.4% | 0.12% | -32.6% |
| T | Sell | AT&T Incequities | $419,000 | -42.0% | 27,331 | -20.7% | 0.10% | -39.6% |
| BOX | Sell | Box Incequities | $353,000 | -25.4% | 14,492 | -23.0% | 0.08% | -22.1% |
| CMCSA | Exit | Comcast Corp Class Aequities | $0 | – | -11,382 | -100.0% | -0.10% | – |
| VWO | Exit | Vanguard FTSE Emerging Markets ETFetf | $0 | – | -13,070 | -100.0% | -0.12% | – |
| VGK | Exit | Vanguard FTSE Europe ETFetf | $0 | – | -221,732 | -100.0% | -2.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-10-31
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp | 39 | Q3 2023 | 1.2% |
| Chevron Corp | 39 | Q3 2023 | 1.0% |
| Facebook Inc Class A | 39 | Q3 2023 | 1.3% |
| AT&T Inc | 39 | Q3 2023 | 0.6% |
| Pfizer Incorporated | 39 | Q3 2023 | 0.3% |
| Cisco Systems Inc | 39 | Q3 2023 | 0.3% |
| Verizon Communications Inc | 39 | Q3 2023 | 0.3% |
| iShares Russell 2000 ETF | 38 | Q2 2023 | 1.4% |
| Vanguard Dividend Appreciation ETF | 37 | Q3 2023 | 8.4% |
| Merck & Co Inc | 37 | Q2 2023 | 0.4% |
View Capital Advantage, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-01-23 |
| 13F-HR | 2023-10-30 |
| 13F-HR | 2023-08-07 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-01-24 |
| 13F-HR | 2022-10-31 |
| 13F-HR | 2022-07-21 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-01-21 |
View Capital Advantage, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.